There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To investigate the efficacy of fenofibrate combination therapy in Chinese patients
with primary biliary cirrhosis (PBC) who had a partial response to standard dose of
ursodeoxycholic acid (UDCA) for at least one year.